(Q34340160)

1 August 2017

1 reference

title

Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications (English)

1 reference

1 August 2017

1 reference

Russell JM

1

1 reference

PubMed ID

11510624

1 August 2017

Mackell JA

series ordinal

2

1 reference

1 August 2017

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

15

1 reference

1 August 2017

7

1 reference

1 August 2017

537-551

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200115070-00004

1 August 2017

0 references

cites work

Olanzapine increases weight and serum triglyceride levels.

1 reference

12 December 2020

Weight gain with risperidone

1 reference

12 December 2020

A survey of prescribing practice of antipsychotic maintenance treatment for manic-depressive outpatients

1 reference

12 December 2020

A prospective study of body mass index, weight change, and risk of stroke in women

1 reference

12 December 2020

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

12 December 2020

Amisulpride versus placebo in the medium-term treatment of the negative symptoms of schizophrenia

1 reference

12 December 2020

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study

1 reference

12 December 2020

Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine.

1 reference

12 December 2020

Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men.

1 reference

12 December 2020

Side effect profiles of new antipsychotic agents

1 reference

12 December 2020

Weight gain associated with neuroleptic medication: a review

1 reference

12 December 2020

Safety profile of amisulpride in short- and long-term use.

1 reference

12 December 2020

Dosing the antipsychotic medication olanzapine

1 reference

12 December 2020

A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia

1 reference

12 December 2020

Weight gain among schizophrenic patients treated with clozapine

1 reference

12 December 2020

The relationship of pharmacology to side effects

1 reference

12 December 2020

Drug-induced weight gain

1 reference

12 December 2020

Complications of obesity

1 reference

12 December 2020

Quetiapine ('Seroquel'); an effective and well-tolerated atypical antipsychotic

1 reference

12 December 2020

Neuropharmacology of obesity: my receptors made me eat it.

1 reference

12 December 2020

Weight gain associated with psychotropic drugs

1 reference

12 December 2020

Clozapine. A novel antipsychotic agent

1 reference

12 December 2020

Review of recent clinical studies with olanzapine

1 reference

12 December 2020

Body weight gain induced by antipsychotic drugs: mechanisms and management

1 reference

12 December 2020

Lithium and body weight gain.

1 reference

12 December 2020

Clozapine-induced weight gain

1 reference

12 December 2020

Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with clozapine for up to 12 years

1 reference

12 December 2020

Atypical antipsychotics and weight gain--a systematic review

1 reference

12 December 2020

Weight gain as a risk factor for clinical diabetes mellitus in women

1 reference

12 December 2020

Cigarette smoking, weight gain, and coronary mortality: results from the Chicago Western Electric Study

1 reference

12 December 2020

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group

1 reference

12 December 2020

Quetiapine : A Review of its Use in Schizophrenia

1 reference

12 December 2020

Olanzapine: weight gain and therapeutic efficacy

1 reference

12 December 2020

Risperidone in the treatment of schizophrenia

1 reference

12 December 2020

A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial

1 reference

12 December 2020

Randomized, double-blind, controlled trial of risperidone versus clozapine in patients with chronic schizophrenia

1 reference

12 December 2020

Weight gain induced by clozapine

1 reference

12 December 2020

Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group

1 reference

12 December 2020

Clozapine-associated elevation in serum triglycerides

1 reference

12 December 2020

Clozapine and associated diabetes mellitus

1 reference

12 December 2020

Recent advances in the pharmacotherapy of schizophrenia

1 reference

12 December 2020

Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months

1 reference

12 December 2020

Clozapine and body mass change.

1 reference

12 December 2020

Measuring outcome in schizophrenia: differences among the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations

1 reference

12 December 2020

Relative weight gain among antipsychotics

1 reference

12 December 2020

Clozapine-induced weight gain: prevalence and clinical relevance

1 reference

12 December 2020

Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.

1 reference

12 December 2020

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

12 December 2020

Novel antipsychotics: comparison of weight gain liabilities.

1 reference

12 December 2020

1 reference

12 December 2020

Weight gain associated with antipsychotic drugs.

1 reference

12 December 2020

Overweight and cancer

1 reference

12 December 2020

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

1 reference

12 December 2020

Weight changes during clozapine treatment

1 reference

12 December 2020

Measurement of appetite disturbances in psychiatric disorders

1 reference

12 December 2020

Weight gain associated with use of psychotropic medications

1 reference

12 December 2020

Olanzapine. A pharmacoeconomic review of its use in schizophrenia

1 reference

12 December 2020

Clozapine and weight gain.

1 reference

12 December 2020

Obesity treatment: examining the premises

1 reference

12 December 2020

Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia

1 reference

12 December 2020

Compliance with antipsychotic drug treatment: influence of side effects.

1 reference

12 December 2020

Amantadine in the treatment of neuroleptic-induced obesity in rats: behavioral, endocrine and neurochemical correlates.

1 reference

12 December 2020

Body weight and leptin plasma levels during treatment with antipsychotic drugs

1 reference

12 December 2020

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

1 reference

12 December 2020

1 reference

12 December 2020

Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial

1 reference

12 December 2020

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

1 reference

12 December 2020

Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913.

1 reference

12 December 2020

Antipsychotic-induced weight gain: a comprehensive research synthesis

1 reference

12 December 2020

Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations

1 reference

12 December 2020

Weight change and risk of heart attack in middle-aged British men.

1 reference

12 December 2020

Physical and psychological consequences of weight gain

1 reference

12 December 2020

Weight gain: side effect of atypical neuroleptics?

1 reference

12 December 2020

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

12 December 2020

ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group

1 reference

12 December 2020

Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications.

1 reference

12 December 2020

Conventional versus atypical neuroleptics: subjective quality of life in schizophrenic patients.

1 reference

12 December 2020

Serum triglyceride levels in patients treated with clozapine

1 reference

12 December 2020

Novel antipsychotics and new onset diabetes

1 reference

12 December 2020

Weight gain with clozapine treatment

1 reference

12 December 2020

Weight gain associated with clozapine

1 reference

12 December 2020

New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment

1 reference

12 December 2020

Psychosocial factors and quality of life in obesity

1 reference

12 December 2020

Diabetes and schizophrenia--a preliminary study.

1 reference

12 December 2020

Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group

1 reference

12 December 2020

Differential effect of clozapine on weight: a controlled study

1 reference

12 December 2020

Bodyweight change as an adverse effect of drug treatment. Mechanisms and management

1 reference

12 December 2020

Hyperglycemia and olanzapine

1 reference

12 December 2020

Nonpharmacologic and pharmacologic management of weight gain.

1 reference

12 December 2020

From chlorpromazine to olanzapine: a brief history of antipsychotics

1 reference

12 December 2020

Assessment of changes in both weight and frequency of use of medications for the treatment of gastrointestinal symptoms among clozapine-treated patients

1 reference

12 December 2020

10.2165/00023210-200115070-00004

Identifiers

DOI

1 reference

PubMed ID

11510624

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

11510624